Skip to main content
. 2018 Sep 26;9(10):1039–1044. doi: 10.1021/acsmedchemlett.8b00344

Table 2. Pharmacokinetic Profiles of GSK583 and 6 in the Sprague–Dawley Rat.

Cmpd IV/oral dose (mg/kg) Cl (mL/min/kg) Vdss (L/kg) IV T1/2 (h) oral Cmax (ng/mL) oral AUC (ng·h/mL) %F free fraction (%)
GSK583 1.0/2.0 15 2.0 7.0 260 980 39 2.6
6 2.0/2.0 12 2.1 4.2 990 3800 82 11.2